收藏切换
Meta analysis of effectiveness and safety of secukinumab in the treatment of psoriatic arthritis
收藏切换
Hua HUANG, Ping LI*, Lin GUO, Xuemei GUO, Chuhui XIONG, Ya GAO, Yumeng YE
World Clinical Drug | 2022, 43(9) : 1171 - 1180
Less
收藏切换
World Clinical Drug | 2022, 43(9): 1171-1180
• Article •
Meta analysis of effectiveness and safety of secukinumab in the treatment of psoriatic arthritis
Full
Hua HUANG, Ping LI*, Lin GUO, Xuemei GUO, Chuhui XIONG, Ya GAO, Yumeng YE
Affiliations
  • Department of Rheumatology and Immunology, General Hospital of Northern Warfare Zone, Shenyang 110016, Liaoning Province, China
Published: 2022-09-10 doi: 10.13683/j.wph.2022.09.016
Outline
收藏切换
Objective

To systematically evaluate the effectiveness and safety of secukinumab in the treatment of psoriatic arthritis (PA).

Methods

Relevant literature on the treatment of PA with secukinumab were searched in English databases (PubMed, MEDLINE, Embase, Cochrance Library) and the Chinese databases (CNKI, VIP, Wanfang), from January 2000 to December 2020. After quality evaluation of the literatures that met the inclusion criteria, the meta analysis was conducted with Revman 5.4 software.

Results

A total of 5 randomized controlled studies involving 2 455 patients with PA were included for analysis. Meta analysis results showed that compared with the treatment of the placebo group, the treatment group with secukinumab significantly improved the patients' remission of American College of Rheumatology (ACR) by 20%[odds ratio (OR)=4.40, 95% confidence interval (CI)(3.79, 5.11), P<0.000 01], ACR50 [OR=5.84, 95%CI (4.82, 7.07), P<0.000 01], ACR70[OR=7.98, 95%CI (5.64, 11.27), P<0.000 01], psoriatic area and severity index (PASI) 75[OR=9.72, 95%CI (6.68, 14.14), P<0.000 01] and PASI90[OR=7.75, 95%CI (4.92, 12.22), P<0.000 01]. Compared with the 150 mg group, the ACR20 in 300 mg secukinumab group was significantly improved [OR=1.36, 95%CI (1.04, 1.76), P=0.02]. In terms of safety, there was no significant difference in the incidence of overall adverse events and serious adverse events between the secukinumab group and the placebo group (P>0.05). The incidence of candida infection and tumor in the secukinumab group was significantly higher than that in the placebo group [OR=2.29, 95%CI (1.18, 4.46), P=0.01, OR=3.38, 95%CI (1.20, 9.53), P=0.02].

Conclusion

The efficacy and safety of secukinumab in the treatment of PA skin lesions and joint lesions are reliable. However, since secukinumab has just been marketed in China, there is no long-term clinical research report, and a large number of clinical studies and further verification are needed in the future.

secukinumab  /  psoriatic arthritis  /  meta analysis
黄华, 李萍, 郭琳, 郭雪美, 熊楚辉, 高雅, 叶雨萌. 司库奇尤单抗治疗银屑病关节炎有效性和安全性的meta分析. 世界临床药物, 2022 , 43 (9) : 1171 -1180 . DOI: 10.13683/j.wph.2022.09.016
Hua HUANG, Ping LI, Lin GUO, Xuemei GUO, Chuhui XIONG, Ya GAO, Yumeng YE. Meta analysis of effectiveness and safety of secukinumab in the treatment of psoriatic arthritis[J]. World Clinical Drug, 2022 , 43 (9) : 1171 -1180 . DOI: 10.13683/j.wph.2022.09.016
Year 2022 volume 43 Issue 9
10
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.09.016
  • Receive Date:2021-11-17
  • Online Date:2026-11-19
  • Published:2022-09-10
Article Data
Affiliations
History
  • Received:2021-11-17
  • Revised:2022-07-22
Affiliations
    Department of Rheumatology and Immunology, General Hospital of Northern Warfare Zone, Shenyang 110016, Liaoning Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.09.016
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT